We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Universal Assay Platform Allows Rapid Blood Grouping

By HospiMedica International staff writers
Posted on 28 Mar 2017
A new study describes how a paper-based point-of-care assay could provide fast and reliable blood group testing at the patient’s bedside.

Developed by researchers at Third Military Medical University, the paper-based assay uses immobilized antibodies and bromocresol green dye for rapid and reliable blood grouping, where dye-assisted color changes corresponding to distinct blood components provide a visual readout for each antigen (A, B, and Rhesus). More...
The researchers also developed a machine-learning method that can classify spectral plots corresponding to the color changes, which enables reproducible automatic grouping.

The assay identifies ABO antigens and five major Rhesus antigens within 30 seconds using small volumes (100 μl) of whole blood, thus allowing simultaneous forward and reverse ABO blood grouping within two minutes through on-chip plasma separation, and all without centrifugation. When tested with optimized operating parameters, the dye-assisted paper assay exhibited comparable accuracy and reproducibility to the classical gel-card assays in grouping 3,550 human blood samples, with more than 99.9% accuracy. The study was published on March 15, 2017, in Science Translational Medicine.

“Fast and simultaneous forward and reverse blood grouping has long remained elusive. Forward blood grouping detects antigens on red blood cells, whereas reverse grouping identifies specific antibodies present in plasma,” concluded lead author Hong Zhang, PhD, and colleagues. “The paper strip could be used in war zones or remote areas where there are no labs to test patients’ blood types. O blood is currently used in these contexts, but supplies are limited.”

There are four major blood groups determined by the presence or absence of two antigens (A and B) on the surface of red blood cells (RBCs). Group A has only the A antigen on RBCs, and B antibody in the plasma; Group B has only the B antigen on RBCs, and A antibody in the plasma; Group AB has both A and B antigens on RBCs, but neither A nor B antibody in the plasma; and Group O has neither A nor B antigens on RBCs, but both A and B antibody in the plasma. In addition to the A and B antigens, there is a third antigen called the rhesus (Rh) factor, which can be either present (+) or absent (–). The universal red cell donor has Type O– blood type, and the universal plasma donor has Type AB+ blood type.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.